Cas9 Stable Cell Line - L-929

The L-929 cell line, originally derived from mouse connective tissue (C3H/An mouse strain), is a mature fibroblast model widely used in biomedical research. These adherent cells exhibit epithelial-like morphology, making them particularly suitable for studying cytotoxicity, cell adhesion, and inflammatory responses. The Cas9 Stable Cell Line - L-929 is a genetically engineered variant in which CRISPR-associated protein 9 (Cas9) is stably integrated into the L-929 genome. This modification ensures the continuous, long-term expression of the Cas9 endonuclease without the need for repeated transfection. This cell line retains the essential characteristics of the parental L-929 cells while enabling precise, on-demand genome editing. Its mouse origin further facilitates translational research, bridging in vitro and in vivo models.

The Cas9 Stable Cell Line - L-929 shows broad application prospects in functional genomics and drug discovery. Researchers use this cell line for high-throughput gene knockout screening to identify genes regulating fibroblast-driven processes such as wound healing, fibrosis, or tumor-stromal interactions. By introducing guide RNA (gRNA) that targets specific genes, scientists can systematically elucidate pathways involved in extracellular matrix remodeling, cytokine signaling (such as TGF-β), or resistance to apoptosis. This cell line also simplifies the construction of homologous disease models, such as creating mutants to mimic fibrotic or cancer-associated fibroblast phenotypes. In the biopharmaceutical field, it accelerates the target validation of antifibrotic or anti-inflammatory therapies.